Ask your provider why those ingredients are included and whether they serve a clinical purpose for your specific situation
Smith, MD, the Institute of Dermatology, London, UK
Z, co-founder of AgelessRx
Interventions that lower blood glucose for 10 years have been shown to reduce the risk of retinopathy and nephropathy [82, 83]
Key Takeaways The Food and Drug Administration (FDA) has approved Semaglutide and most GLP-1 receptor agonist medications to improve glycemic control in type 2 diabetes and aid in weight management for individuals with weight-related conditions
Karacabeyli D, Lacaille D, Lu Nea et al (2024) Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: a population-based study